Search - tctmd.com

Displaying 401 - 420 of 774

Sort: Relevancy | Date

Presentation NY Valves 2024

Will New VHD Screening Methods Address or Exacerbate Healthcare Disparities?

Presenter: Suzanne J. Baron

June 06, 2024

Presentation NY Valves 2024

J-Valve

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes

Presenter: Annette Maznyczka

June 06, 2024

Presentation NY Valves 2024

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

SAVR Will Have a Longer Lasting Durability Than TAVR

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

TAV-in-TAV With a 23mm SAPIEN3 Ultra Resilia in a Degenerated 23mm SAPIEN3 Valve

Presenter: Supawat Ratanapo

June 06, 2024

Presentation NY Valves 2024

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

Presenter: Jörg Hausleiter

June 06, 2024

Presentation NY Valves 2024

TMVR Following Failed M-TEER: Technical and Procedural Considerations

Presenter: Rodrigo D. Estevez-Loureiro

June 06, 2024

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Presentation NY Valves 2024

My First Choice Would Be Balloon Expandable Valves!

Presenter: Helene Eltchaninoff

June 06, 2024

Presentation NY Valves 2024

JenaValve

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

Designing Trials to Assess the Effectiveness of New VHD Screening Strategies

Presenter: Timothy Joseph Poterucha

June 06, 2024

Presentation NY Valves 2024

SMART Says That Self Expanding Valves Are Best!

Presenter: Howard C. Herrmann

June 06, 2024

Presentation NY Valves 2024

TAVI Valve-in-Valve-in-Valve: A Case Report of Viv Redo Procedure

Presenter: Maciej Mazurek

June 06, 2024

Presentation NY Valves 2024

Metanalysis of Clinical and Hemodynamic Differences in Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus

Presenter: Errol Christopher Moras

June 06, 2024

Presentation NY Valves 2024

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Presenter: Mark Lebehn

June 06, 2024

Presentation NY Valves 2024

Gradients After Transcatheter Aortic Valve Replacements Are Impacted by Both Body Mass Index and Valve Size

Presenter: Akhil Reddy

June 06, 2024

Presentation NY Valves 2024

Bioprosthetic Valve Fracture for Mitral ViV Therapy: Indication, Technique and Outcomes

Presenter: John Thomas Saxon

June 06, 2024

Presentation NY Valves 2024

Cases 1/2 : TAVR at 8 Years and SVD at 2 Years

Presenter: Guillaume Bonnet

June 06, 2024

Presentation NY Valves 2024

TRISCEND II: Understanding the Study Design and Interpreting the Results

Presenter: Susheel K. Kodali

June 06, 2024

Advertisement

Will New VHD Screening Methods Address or Exacerbate Healthcare Disparities?

J-Valve

Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

SAVR Will Have a Longer Lasting Durability Than TAVR

TAV-in-TAV With a 23mm SAPIEN3 Ultra Resilia in a Degenerated 23mm SAPIEN3 Valve

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

TMVR Following Failed M-TEER: Technical and Procedural Considerations

TAVR Will Have a Longer Lasting Durability Than SAVR

My First Choice Would Be Balloon Expandable Valves!

JenaValve

Designing Trials to Assess the Effectiveness of New VHD Screening Strategies

SMART Says That Self Expanding Valves Are Best!

TAVI Valve-in-Valve-in-Valve: A Case Report of Viv Redo Procedure

Metanalysis of Clinical and Hemodynamic Differences in Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Gradients After Transcatheter Aortic Valve Replacements Are Impacted by Both Body Mass Index and Valve Size

Bioprosthetic Valve Fracture for Mitral ViV Therapy: Indication, Technique and Outcomes

Cases 1/2 : TAVR at 8 Years and SVD at 2 Years

TRISCEND II: Understanding the Study Design and Interpreting the Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content